EUS-PCSS-T demonstrated superior variceal eradication, reduced procedural burden, and improved safety versus earlier techniques. While rebleeding/survival differences were non-significant, it represents a technically optimized approach for GOV-type EGVB secondary prophylaxis. Prospective validation warranted.
Zhang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: